Investment Stage

Focus Areas

About Investor

Pablo Lubroth is an Investor at Hummingbird Ventures and a VP of Special Projects at Enveda. He invests across Pre-seed through Series B in biotech and pharma (including therapeutics), and also backs digital health and deep tech, with a typical investment range of $500K–$5.0M. He built and led Hummingbird’s biotech practice and has led investments across therapeutics, tools, and software. His background includes degrees from University College London and the University of Cambridge, plus corporate development work at a genome-editing company, and he is a Co-Founder and Editor at Decoding Bio.